Raymond James & Associates’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NOVT
CCA
WA
Raymond James & Associates's NOVT Position: Q3 2024 in Review
Raymond James & Associates reduced its Novanta (NOVT) stake by 2.1% in Q3 2024, selling an estimated $184K and leaving 49,580 shares worth $8.87M. The position accounts for 0.01% of the portfolio, ranked #1294.
Raymond James & Associates first reported a position in NOVT in Q2 2021 and has held it in 14 quarters since. 288 funds tracked by Wall St. Rank hold NOVT as of Q3 2024.
- Raymond James & Associates held 49,580 shares of Novanta worth $8.87M as of Q3 2024.
- Raymond James & Associates sold 1,060 Novanta shares in Q3 2024, an estimated $184K.
- Novanta made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1294 holding.
- Raymond James & Associates first reported a position in Novanta in Q2 2021 and has held it in 14 quarters since.
- 288 funds tracked by Wall St. Rank held Novanta as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.